{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:36:27Z","timestamp":1763768187078,"version":"3.45.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.jvir.2025.07.018","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T16:30:12Z","timestamp":1763742612000},"page":"1876-1881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Advances in Radioembolization for Liver Cancer"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9612-5570","authenticated-orcid":false,"given":"Sam","family":"Meiselman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Allan","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Daniel","family":"Giardina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1054-3768","authenticated-orcid":false,"given":"Alexander","family":"Zheleznyak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2437-1239","authenticated-orcid":false,"given":"Daniel L.J.","family":"Thorek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Malone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2025.07.018_bib1","doi-asserted-by":"crossref","first-page":"694","DOI":"10.6004\/jnccn.2023.0035","article-title":"NCCN Guidelines\u00ae insights: biliary tract cancers, version 2.2023","volume":"21","author":"Benson","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jvir.2025.07.018_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.101567","article-title":"The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO\/World Congress on Gastrointestinal Cancer, Barcelona, 2022","volume":"8","author":"Ducreux","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.jvir.2025.07.018_bib3","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jvir.2025.07.018_bib4","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2025.07.018_bib5","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s00270-020-02538-x","article-title":"Feasibility of combination intra-arterial yttrium-90 and irinotecan microspheres in the VX2 rabbit model","volume":"43","author":"Gordon","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2025.07.018_bib6","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1021\/acsnano.0c09122","article-title":"Highly tumor-specific and long-acting iodine-131 microbeads for enhanced treatment of hepatocellular carcinoma with low-dose radio-chemoembolization","volume":"15","author":"Qian","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.jvir.2025.07.018_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202301559","article-title":"Radioiodine-131-labeled theranostic nanoparticles for transarterial radioembolization and chemoembolization combination therapy of VX2 liver tumor","volume":"12","author":"Jia","year":"2023","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.jvir.2025.07.018_bib8","doi-asserted-by":"crossref","first-page":"12669","DOI":"10.1021\/acsami.2c19829","article-title":"Polydopamine-coated radiolabeled microspheres for combinatorial radioembolization and photothermal cancer therapy","volume":"15","author":"Wu","year":"2023","journal-title":"ACS Appl Mater Interfaces"},{"key":"10.1016\/j.jvir.2025.07.018_bib9","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jcis.2023.03.111","article-title":"Radionuclide labeled nanocarrier for imaging guided combined radionuclide, sonodynamic, and photothermal therapy of pancreatic tumours","volume":"642","author":"An","year":"2023","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.jvir.2025.07.018_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031402","article-title":"Quantitative modeling of Cerenkov light production efficiency from medical radionuclides","volume":"7","author":"Beattie","year":"2012","journal-title":"PLoS One"},{"issue":"Suppl","key":"10.1016\/j.jvir.2025.07.018_bib11","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1016\/j.jvir.2022.12.127","article-title":"Abstract No. 81 Assessing novel nano-photosensitizer hepatocellular carcinoma (HCC) tumor uptake in vivo as a candidate platform to enhance 90Y radioembolization","volume":"34","author":"Malone","year":"2023","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2025.07.018_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-17185-0","article-title":"Activation of nano-photosensitizers by Y-90 microspheres to enhance oxidative stress and cell death in hepatocellular carcinoma","volume":"12","author":"Malone","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jvir.2025.07.018_bib13","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1001\/jamaoncol.2018.3923","article-title":"Fatal toxic effects associated with immune checkpoint inhibitors: a systematic review and meta-analysis","volume":"4","author":"Wang","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jvir.2025.07.018_bib14","doi-asserted-by":"crossref","first-page":"e1036","DOI":"10.1002\/onco.13638","article-title":"The role of immunotherapy in hepatocellular carcinoma: a systematic review and pooled analysis of 2,402 patients","volume":"26","author":"Ziogas","year":"2021","journal-title":"Oncologist"},{"key":"10.1016\/j.jvir.2025.07.018_bib15","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","article-title":"Delivery technologies for cancer immunotherapy","volume":"18","author":"Riley","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jvir.2025.07.018_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/natrevmats.2016.14","article-title":"Analysis of nanoparticle delivery to tumours","volume":"1","author":"Wilhelm","year":"2016","journal-title":"Nat Rev Mater"},{"key":"10.1016\/j.jvir.2025.07.018_bib17","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005457","article-title":"Nivolumab after selective internal radiation therapy for the treatment of hepatocellular carcinoma: a phase 2, single-arm study","volume":"10","author":"de la Torre-Al\u00e1ez","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jvir.2025.07.018_bib18","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1158\/1078-0432.CCR-23-0581","article-title":"A phase I\/IIa trial of yttrium-90 radioembolization in combination with durvalumab for locally advanced unresectable hepatocellular carcinoma","volume":"29","author":"Lee","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jvir.2025.07.018_bib19","doi-asserted-by":"crossref","first-page":"270-e413","DOI":"10.1093\/oncolo\/oyad331","article-title":"A pilot study of pembrolizumab in combination with Y90 radioembolization in subjects with poor prognosis hepatocellular carcinoma","volume":"29","author":"Yu","year":"2024","journal-title":"Oncologist"},{"key":"10.1016\/j.jvir.2025.07.018_bib20","article-title":"Silk embolic material for catheter-directed endovascular drug delivery","volume":"34","author":"Hu","year":"2022","journal-title":"Adv Mater"},{"key":"10.1016\/j.jvir.2025.07.018_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/CJI.0000000000000235","article-title":"Intra-arterial versus intravenous adoptive cell therapy in a mouse tumor model","volume":"41","author":"Visioni","year":"2018","journal-title":"J Immunother"},{"key":"10.1016\/j.jvir.2025.07.018_bib22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.jconrel.2024.12.064","article-title":"Iodine-131 radioembolization boosts the immune activation enhanced by icaritin\/resiquimod in hepatocellular carcinoma","volume":"378","author":"Li","year":"2025","journal-title":"J Control Release"},{"issue":"Suppl","key":"10.1016\/j.jvir.2025.07.018_bib23","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1200\/JCO.2024.42.16_suppl.2622","article-title":"PERIO-02: phase 1b pressure enabled regional immuno-oncology trial of nelitolimod (SD-101), a class C TLR9 agonist, delivered via hepatic artery infusion +\/\u2212 checkpoint inhibition in intrahepatic cholangiocarcinoma and hepatocellular carcinoma","volume":"42","author":"Lee","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jvir.2025.07.018_bib24","article-title":"Preliminary evaluation of alpha-emitting radioembolization in animal models of hepatocellular carcinoma","volume":"17","author":"Du","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.jvir.2025.07.018_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.1021499","article-title":"The inhibiting effect of alpha-based TARE on embolized vessels and neovascularization","volume":"10","author":"Tong","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jvir.2025.07.018_bib26","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1088\/0031-9155\/59\/13\/3353","article-title":"A small-scale anatomical dosimetry model of the liver","volume":"59","author":"Stenvall","year":"2014","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.jvir.2025.07.018_bib27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2967\/jnumed.123.266571","article-title":"Beyond average: \u03b1-particle distribution and dose heterogeneity in bone metastatic prostate cancer","volume":"65","author":"Benabdallah","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jvir.2025.07.018_bib28","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.zemedi.2020.09.002","article-title":"Assessment of the radiation exposure of relatives and caregivers of patients treated with Ra-223\u2014results of a German multicenter study","volume":"31","author":"Wanke","year":"2021","journal-title":"Z Med Phys"},{"key":"10.1016\/j.jvir.2025.07.018_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.149223","article-title":"A radionuclide-labeled nanomedicine for STING pathway activation- and oxygenation-augmented orthotopic cancer radioisotope-immunotherapy","volume":"483","author":"Luo","year":"2024","journal-title":"Chem Eng J"},{"key":"10.1016\/j.jvir.2025.07.018_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/smll.201903628","article-title":"Hybrid protein nano-reactors enable simultaneous increments of tumor oxygenation and iodine-131 delivery for enhanced radionuclide therapy","volume":"15","author":"Chen","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.jvir.2025.07.018_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.cjac.2024.100414","article-title":"Radiosensitizer-based injectable hydrogel for enhanced radio-chemotherapy of TNBC","volume":"52","author":"An","year":"2024","journal-title":"Chin J Anal Chem"},{"key":"10.1016\/j.jvir.2025.07.018_bib32","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.jhep.2022.08.021","article-title":"Global burden of primary liver cancer in 2020 and predictions to 2040","volume":"77","author":"Rumgay","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jvir.2025.07.018_bib33","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/ije\/dyaa196","article-title":"Global Trend of aetiology-based primary liver cancer incidence from 1990 to 2030: a modelling study","volume":"50","author":"Liu","year":"2021","journal-title":"Int J Epidemiol"},{"issue":"Suppl 1","key":"10.1016\/j.jvir.2025.07.018_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2025.07.018_bib35","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.4254\/wjh.v7.i18.2147","article-title":"Strategies to increase the resectability of hepatocellular carcinoma","volume":"7","author":"She","year":"2015","journal-title":"World J Hepatol"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044325004993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1051044325004993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T23:26:55Z","timestamp":1763767615000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1051044325004993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1051044325004993"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2025.07.018","relation":{},"ISSN":["1051-0443"],"issn-type":[{"type":"print","value":"1051-0443"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in Radioembolization for Liver Cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2025.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR 2025 .","name":"copyright","label":"Copyright"}]}}